These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1475622

  • 1. Gastroduodenal lesions associated with two different piroxicam formulations. An endoscopic comparison.
    Aabakken L, Olaussen B, Mowinckel P, Osnes M.
    Scand J Gastroenterol; 1992 Dec; 27(12):1049-54. PubMed ID: 1475622
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
    Lipscomb GR, Wallis N, Armstrong G, Rees WD.
    Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of microencapsulated vs. enteric-coated acetylsalicylic acid on gastric and duodenal mucosa: an endoscopic study.
    Malfertheiner P, Stanescu A, Rogatti W, Ditschuneit H.
    J Clin Gastroenterol; 1988 Jun; 10(3):269-72. PubMed ID: 2980760
    [Abstract] [Full Text] [Related]

  • 10. Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers.
    Blondon H, Barbier JP, Mahé I, Deverly A, Kolsky H, Bergmann JF.
    Fundam Clin Pharmacol; 2000 Jun; 14(2):155-7. PubMed ID: 10796063
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers.
    Aabakken L, Axelsson CK, Szecsi PB.
    Scand J Gastroenterol; 1993 Jun; 28(6):557-60. PubMed ID: 8322031
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic findings in the stomach and duodenum after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
    Oddsson E, Gudjonsson H, Thjodleifsson B.
    Scand J Gastroenterol; 1990 Mar; 25(3):231-4. PubMed ID: 2181621
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract.
    Aabakken L, Larsen S, Osnes M.
    Scand J Rheumatol; 1989 Mar; 18(6):361-8. PubMed ID: 2515593
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [High-dose ranitidine protects stomach and duodenum completely against piroxicam. An endoscopic double-blind pilot study].
    Müller P, Leucht U, Simon B.
    Z Gastroenterol; 1992 Dec; 30(12):851-3. PubMed ID: 1481550
    [Abstract] [Full Text] [Related]

  • 18. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study.
    Chowdhury A, Ganguly G, Chowdhury D, Santra A, Gupta JD, Roy T.
    Indian J Gastroenterol; 2001 Dec; 20(6):227-9. PubMed ID: 11817775
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.